Gulf Times - covid-19-vaccine
Pfizer seeks UK approval for use of Covid-19 vaccine in teenagers

Pfizer seeks UK approval for use of Covid-19 vaccine in teenagers

Pfizer is seeking British approval for the use of its Covid-19 vaccine among 12- to 15-year olds and has submitted data to the health regulator, a company representative said on Tuesday, paving the way for inoculation of adolescents in the country.

Fully vaccinated enjoy new freedoms in Germany

Fully vaccinated enjoy new freedoms in Germany

People who have been fully vaccinated against Covid-19 are exempt from many restrictions in Germany from Sunday after the government passed new legislation to restore some freedoms.

EU regulator reviews reports of rare nerve disorder after AstraZeneca shot

EU regulator reviews reports of rare nerve disorder after AstraZeneca shot

Europe's medicines regulator said on Friday it was reviewing reports of a rare nerve-degenerating disorder in people who have received AstraZeneca's Covid-19 vaccine, and requested more detailed data on the cases from the company.

Pfizer bets on Covid-19 vaccine demand for years, sees sales of $26bn in 2021

Pfizer bets on Covid-19 vaccine demand for years, sees sales of $26bn in 2021

Pfizer Inc on Tuesday raised its forecast for 2021 Covid-19 vaccine sales by more than 70% to $26 billion and said demand from governments around the world trying to halt the pandemic could contribute to its growth for years to come.

Pfizer/BioNTech seek Covid jab approval for 12-15-year-olds in EU

Pfizer/BioNTech seek Covid jab approval for 12-15-year-olds in EU

Pfizer/BioNTech said Friday they have asked European regulators to authorise their Covid-19 vaccine for 12- to 15-year-olds, a move seen as a crucial step toward achieving herd immunity.

EU backs AstraZeneca's Covid-19 vaccine as reviews into blood clots continue

EU backs AstraZeneca's Covid-19 vaccine as reviews into blood clots continue

Europe's drug regulator reiterated on Friday that benefits of AstraZeneca's Covid-19 vaccine outweigh any risks, as part of a detailed guidance from ongoing reviews into rare blood clots to help individual nations determine the shot's use.

Nepal approves Russia's Sputnik V Covid-19 vaccine

Nepal approves Russia's Sputnik V Covid-19 vaccine

Nepal gave conditional approval on Tuesday for the emergency use of the Russian Sputnik V Covid-19 vaccine, an official of the drug regulator said, as the country recorded the highest daily increase of infections in four months.

Canada records second case of rare blood clot after AstraZeneca shot

Canada records second case of rare blood clot after AstraZeneca shot

Canadian health authorities said Saturday the country has recorded a second case of rare but serious blood clotting linked to AstraZeneca's Covid-19 vaccine, but still recommend the shot for use.

Qatar's Covid Vaccination Programme reaches millionth dose milestone

Qatar's Covid Vaccination Programme reaches millionth dose milestone

The Ministry of Public Health (MoPH) on Wednesday announced the administration of the one millionth Covid-19 vaccine dose in Qatar.

Qatar Airways Cargo transports 1.5mn doses of vaccine for Qatar

Qatar Airways Cargo transports 1.5mn doses of vaccine for Qatar

Qatar Airways Cargo has crossed a milestone transport of over 1.5mn Covid-19 vaccine doses into Qatar, with its largest batch of more than 530,000 Pfizer and Moderna vaccines arriving from Amsterdam on Monday.

1 out of 4 adults gets at least one dose of Covid-19 vaccine

1 out of 4 adults gets at least one dose of Covid-19 vaccine

The Ministry of Public Health (MoPH) has announced that one out of four adults in the country has received at least one dose of the Covid-19 vaccine since the start of Qatar's National Covid-19 Vaccination Programme

Pfizer Covid-19 vaccine safe, effective on adolescents in trial, companies say

Pfizer Covid-19 vaccine safe, effective on adolescents in trial, companies say

Pfizer Inc and BioNTech SE said on Wednesday their Covid-19 vaccine was safe and effective and produced robust antibody responses in 12- to 15-year olds, paving the way for them to seek US emergency use authorization in weeks.